The company operates in the Sleep Apnea Devices industry, which is forecast for strong growth from $6.47 billion in 2024 to $12.23 billion by 2033, representing a compound annual growth rate of 7.32%. This expansion is driven by rising global rates of sleep disorders like obstructive sleep apnea, fueled by factors such as obesity. Key growth drivers benefiting the company include increased health awareness, improved healthcare infrastructure, and ongoing technological advancements in sleep devices.